Aligos Therapeutics Inc (ALGS)vsRevolution Medicines Inc (RVMD)
ALGS
Aligos Therapeutics Inc
$4.91
-8.05%
HEALTHCARE · Cap: $32.49M
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Aligos Therapeutics Inc generates 534% more annual revenue ($4.71M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. ALGS earns a higher WallStSmart Score of 37/100 (F).
ALGS
Hold37
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-5.8%
Fair Value
$7.05
Current Price
$4.91
$2.14 premium
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 810.0% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ALGS
The strongest argument for ALGS centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 810.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ALGS
The primary concerns for ALGS are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
ALGS profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
ALGS carries more volatility with a beta of 2.28 — expect wider price swings.
ALGS is growing revenue faster at 810.0% — sustainability is the question.
ALGS generates stronger free cash flow (-23M), providing more financial flexibility.
Bottom Line
ALGS scores higher overall (37/100 vs 24/100) and 810.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aligos Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing novel therapies to address unmet medical needs in viral and liver diseases. The company is headquartered in South San Francisco, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?